We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.8B
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+15.94%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.73B
AUM Growth
+$152M
(+9.7%)
Cap. Flow
-$38.6M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Establishment Labs
ESTA
|
+$11.2M |
| 2 |
Prestige Consumer Healthcare
PBH
|
+$6.68M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$6.54M |
| 4 |
Addus HomeCare
ADUS
|
+$3.51M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
+$2.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBBY
Bed Bath & Beyond
BBBY
|
+$11.2M |
| 2 |
Stride
LRN
|
+$9.83M |
| 3 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$9.14M |
| 4 |
Axos Financial
AX
|
+$5.93M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.1% |
| 2 | Technology | 23.78% |
| 3 | Industrials | 19.76% |
| 4 | Consumer Discretionary | 6.36% |
| 5 | Communication Services | 6.01% |
Similar funds
GC
BP
CIM
JCM
KPM
BFG
ST
MCC
Rice Hall James & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Rice Hall James & Associates held 270 positions worth $1.73B, up 9.7% from $1.57B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Rice Hall James & Associates's Q4 2023 filing shows 10 new, 28 increased, 188 reduced and 10 closed positions. Its largest new stake was Addus HomeCare: 40,418 shares worth $3.75M. The largest sale was Bed Bath & Beyond, an estimated $11.2M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
- Rice Hall James & Associates's largest Q4 2023 buy was Addus HomeCare: 40,418 shares worth $3.75M.
- Rice Hall James & Associates added most to Establishment Labs in Q4 2023, an estimated $11.2M increase.
- Rice Hall James & Associates's biggest Q4 2023 reduction was Bed Bath & Beyond, cutting an estimated $11.2M.
- Rice Hall James & Associates fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $9.14M.
- Rice Hall James & Associates's ten largest holdings make up 25% of its $1.73B portfolio in Q4 2023.
- Rice Hall James & Associates opened 10 new positions and closed 10 in Q4 2023.
- Rice Hall James & Associates's portfolio value rose 9.7% quarter-over-quarter to $1.73B.
Based on Rice Hall James & Associates's 13F filing for Q4 2023, filed 9 Feb 2024.